41 results on '"Yasunori Itoh"'
Search Results
2. MP67-10 IDENTIFICATION OF URINARY MACROPHAGE-RELATED FACTORS SPECIFIC TO PATIENTS WITH CALCIUM OXALATE STONES USING MULTIPLEX ANALYSIS
3. PD31-01 ADMINISTRATION OF THE SELECTIVE ALPHA 1A ADRENOCEPTOR ANTAGONIST SILODOSIN FACILITATES EXPULSION OF SIZE 5 - 10 MM DISTAL URETERAL STONES, AS COMPARED TO CONTROL
4. MP67-15 DIFFERENT ROLES OF M1/M2 MACROPHAGE PHENOTYPE FOR RENAL CRYSTAL FORMATION
5. A Polymorphism of Matrix Gla Protein Gene is Associated With Kidney Stones
6. MP34-13 PPAR-α/γ AGONISTS HAVE DIFFERENT EFFECTS ON RENAL CRYSTAL FORMATION IN HYPEROXALURIC ANIMAL MODELS
7. MP41-06 ADMINISTRATION OF THE SELECTIVE ALPHA 1A ADRENOCEPTOR ANTAGONIST SILODOSIN FACILITATES EXPULSION OF SIZE 5 - 10 MM DISTAL URETERAL STONES, AS COMPARED TO CONTROL
8. MP80-18 GENETIC DIAGNOSIS TRIAL BY SINGLE NUCLEOTIDE POLYMORPHISM ANALYSIS FROM A CASE-CONTROL STUDY, USING THREE NOVEL LOCI ASSOCIATED WITH SUSCEPTIBILITY TO UROLITHIASIS FROM A GENOME-WIDE ASSOCIATION STUDY (GWAS)
9. MP41-03 ALENDRONATE HAS A PREVENTIVE EFFECT FOR UROLITHIASIS RECURRENCE IN MEN AND POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
10. MP25-03 THREE NOVEL LOCI ASSOCIATED WITH SUSCEPTIBILITY TO UROLITHIASIS FROM A GENOME-WIDE ASSOCIATION STUDY: A CASE-CONTROL ASSOCIATION STUDY
11. MP25-04 POSSIBLE NEW URINE MARKERS FOR CALCIUM OXALATE 'STONE FORMERS': MACROPHAGE-RELATED CYTOKINES/CHEMOKINES DETECTED BY MULTIPLEX ANALYSIS
12. 1823 EFFECT OF AN ULTRASONIC TARGETING METHOD FOR KIDNEY AND PROXIMAL URETER STONES ON THE SUCCESS RATE OF SHOCK WAVE LITHOTRIPSY
13. 1557 DEVELOPMENT OF A NOVEL METHOD FOR MEASURING SERUM OXALATE BY USING A TRIS(2,2'-BIPYRIDYL) RUTHENIUM(II) CHEMILUMINESCENCE ANALYSIS SYSTEM, AND ITS IMPORTANCE FOR UROLITHIASIS PATIENTS
14. 2082 ASSOCIATION OF THE LOCI 5Q35.3, 7Q14.3, AND 13.Q14.1 WITH UROLITHIASIS: A CASE-CONTROL STUDY IN THE JAPANESE POPULATION, INVOLVING GENOME-WIDE ASSOCIATION STUDY
15. 2085 MACROPHAGE-COLONY STIMULATING FACTOR (M-CSF) IS A NOVEL PREVENTIVE AGENT AGAINST RENAL STONE DISEASE BY INDUCING ANTI-INFLAMMATORY MACROPHAGES
16. 2086 RENAL MACROPHAGES COULD ENGLOBE CALCIUM OXALATE CRYSTALS DURING KIDNEY STONE FORMATION IN VITRO AND IN VIVO MODELS
17. 2088 ADMINISTRATION OF THE SELECTIVE ALPHA 1A ADRENOCEPTOR ANTAGONIST SILODOSIN FACILITATES EXPULSION OF 1.5 MM OR LARGER DISTAL URETERAL STONES, AS COMPARED TO CONTROL
18. 2303 BISPHOSPHONATE PREVENTS UROLITHIASIS IN MEN WITH OSTEOPOROSIS BY REDUCING THE URINARY ION ACTIVITY PRODUCT OF CALCIUM STONE
19. 2087 CRYSTAL KINETICS AND PROCESSING IN HUMAN KIDNEY STONE FORMATION: COMPARISON OF CLINICAL AND PATHOLOGICAL FINDINGS IN STONE FORMERS AND NON-STONE FORMERS
20. 2122 THE ROLE OF LONG-TERM LOADING OF CHOLESTEROL IN RENAL CRYSTAL FORMATION
21. 2145 MACROPHAGE-COLONY STIMULATING FACTOR–DEFICIENT MICE DEMONSTRATE THAT MACROPHAGES PLAY A DEFENSIVE ROLE AGAINST RENAL STONE FORMATION
22. 2053 ASSOCIATION BETWEEN UROLITHIASIS AND FOOD INTAKE BASED ON DATA FROM A JAPANESE NATIONAL SURVEY
23. 2224 BISPHOSPHONATE PREVENTS THE RECURRENCE OF UROLITHIASIS IN POSTMENOPAUSAL WOMAN WITH OSTEOPOROSIS
24. 2140 IDENTIFICATION OF NEW SUSCEPTIBILITY LOCI FOR NEPHROLITHIASIS USING A GENOME-WIDE ASSOCIATION STUDY
25. 2047 PIOGLITAZONE, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA@(PPAR- f Á) ACTIVATOR, POSSIBLY INHIBITS RENAL STONE FORMATION IN RATS
26. 2049 RENAL MACROPHAGE MIGRATION AND CRYSTAL PHAGOCYTOSIS VIA INFLAMMATORY-RELATED GENE EXPRESSION DURING KIDNEY STONE FORMATION AND ELIMINATION IN MICE
27. 1971 THE ROLE OF LONG-TERM LOADING OF CHOLESTEROL IN RENAL CRYSTAL FORMATION
28. 2116 DEVELOPMENT OF A NEW METHOD FOR MEASURING SERUM OXALATE USING A TRIS(2,2′-BIPYRIDYL)RUTHENIUM(II) CHEMILUMINESCENCE ANALYSIS SYSTEM AND IMPORTANCE IN UROLITHIASIS PATIENTS
29. 1532: Eicosapentaenoic Acid Prevent the Recurrence of Nephrolithiasis
30. 1133: Bisphosphonate Inhibits Urinary Stone Formation by MDCK Cells in A Three-Dimensional Culture Model
31. EFFECTS OF MICROGRAVITY ENHANCEMENT OF OXIDATIVE STRESS IN HUMAN RENAL TUBULAR CELLS
32. THE MELAMINE STONE : THE MECHANISM OF RENAL CALCULUS FORMATION FROM MELAMINE EXPOSURE
33. THE ROLE OF NF-κB ON RENAL STONE FORMATION
34. ALENDRONATE HAS A PREVENTIVE EFFECT ON THE RECURRENCE OF NEPHROLITHIASIS BY REDUCING THE RISK FACTORS OF CALCIUM STONE
35. OSTEOPONTIN HAS A CRUCIAL ROLE IN ULTRASTRUCTURAL CONVERSION OF CALCIUM OXALATE CRYSTALS INTO MATRIX- INVOLVING KIDNEY STONES
36. BISPHOSPHONATE DECREASES URINARY ION ACTIVITY PRODUCT OF CALCIUM PHOSPHATE IN POSTMENOPAUSAL WOMAN WITH UROLITHIASIS AND OSTEOPOROSIS
37. EXPRESSION LEVEL AND ROLE IN URETERAL CONTRACTION OF ALPHA1-ADRENOCEPTOR SUBTYPES IN HUMAN URETER
38. 1643: Bisphosphonate Prevents Calcium Phosphate Stones in Patients with Osteoporosis
39. 1632: Morphological Conversion of Calcium Oxalate Crystals into Stones is Regulated by the Presence of Osteopontin in Hyperoxaluric Mouse Kidney
40. 1531: Pamidrinate has Preventive Effect on Kidney Stone Formation Induced by 90-Days Bed Rest Test
41. 1124: Do Mice have a Key to Conquer Urolithiasis?- Mice may Delete Calcium Oxalate Crystal Deposits from their Kidney with Osteopontin
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.